Published inMolecule Blog·Jan 28, 2022The Emergence of Biotech DAOsA blossoming Decentralized Science (DeSci) movement is changing the biopharma landscape by enabling the formation of patient- and researcher-centric communities building with an open-source ethos. Breaking Eroom’s Law We are all familiar with Moore’s Law - the observation that the number of transistors in a dense integrated circuit doubles about…Biotech8 min readBiotech8 min read
Published inMolecule Blog·Aug 19, 2021IP-NFTs for Researchers: A New Biomedical Funding ParadigmTL;DR: This week, the first university biomedical intellectual property (IP) and research project was funded as an NFT (non-fungible token), enabled by a pioneering innovation at Molecule. The IP-NFT enables new fundraising and collaboration strategies for researchers by combining legal and technical frameworks with NFT technology. …Nft9 min readNft9 min read
Published inMolecule Blog·Oct 1, 2020Molecule and the Search for Longevity TherapeuticsIn a few short weeks, we will be launching one of our flagship longevity projects with the University of Copenhagen’s Center for Healthy Aging. Here, our Chief Scientific Officer, Tyler Golato, discusses why Molecule is doubling down on longevity. The Importance of Longevity Throughout human history, the idea of slowing down the aging process…Aging7 min readAging7 min read
Published inMolecule Blog·Apr 24, 2020The Impact of COVID-19 on Science, Publishing, and Drug DevelopmentThe Defining Event of Our Lifetimes At the beginning of this year, the world was a different place, unrecognisable compared to the world we inhabit today. Over the past three months, we have witnessed the fabric of society change in profound ways previously unfathomable. We are living through, perhaps, the…Covid-198 min readCovid-198 min read
Published inMolecule Blog·Feb 10, 2020Molecule and Arctoris announce partnership to tackle the innovation crisis in drug development.The pharmaceutical industry is facing a wide variety of challenges, but perhaps the most pressing is the ongoing innovation crisis. Drug discovery rates are declining, the price of bringing a drug to market is increasing, and ROI on R&D is expected to hit 0% in the next few years. Taken…3 min read3 min read
Published inMolecule Blog·Jun 4, 2019Funding Late Stage Clinical Development of a Novel AntimalarialMolecule Case Study Series — Thanks to Titian Steiger for his insights and contributing toward the bonding curve modelling for this article. This article examines a potential use case for Molecule, identifying various ways that the platform could enable universities to compete in an increasingly complex and expensive drug development landscape. Although the article examines…Healthcare11 min readHealthcare11 min read
Published inMolecule Blog·Apr 9, 2019The Future of Drug Development is OpenPharma Macroeconomics: A Looming Crisis — “There is no single cause or solution to the persistent and burgeoning problem of lack of access to medicines and health technologies; but there must be single-mindedness in the global commitment to confront it.” This was the conclusion and call-to-action of a long-awaited 2016 UN report, which recommended that World…Healthcare11 min readHealthcare11 min read
